Home > Qtrly Results > MANKIND PHARMA

MANKIND PHARMA
Quarterly Results Analysis [Mar2024]

MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Quarterly Results

Consolidated Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Revenues ₹2,441 Cr ₹2,607 Cr ₹2,708 Cr ₹2,579 Cr ₹2,053 Cr ₹2,091 Cr ₹2,426 Cr ₹2,180 Cr
Expenses ₹1,850 Cr ₹2,000 Cr ₹2,025 Cr ₹1,924 Cr ₹1,636 Cr ₹1,654 Cr ₹1,835 Cr ₹1,724 Cr
Operating Income ₹591 Cr ₹607 Cr ₹683 Cr ₹655 Cr ₹417 Cr ₹437 Cr ₹591 Cr ₹456 Cr
Other Income ₹92 Cr ₹70 Cr ₹60 Cr ₹59 Cr ₹48 Cr ₹37 Cr ₹27 Cr ₹17 Cr
Interest ₹9 Cr ₹9 Cr ₹9 Cr ₹6 Cr ₹5 Cr ₹13 Cr ₹10 Cr ₹16 Cr
Depreciation ₹105 Cr ₹110 Cr ₹96 Cr ₹87 Cr ₹85 Cr ₹85 Cr ₹79 Cr ₹78 Cr
Profit Before Tax ₹569 Cr ₹558 Cr ₹638 Cr ₹620 Cr ₹375 Cr ₹377 Cr ₹529 Cr ₹378 Cr
Profit After Tax ₹474 Cr ₹455 Cr ₹508 Cr ₹489 Cr ₹291 Cr ₹293 Cr ₹419 Cr ₹294 Cr
EPS ₹11.76 ₹11.33 ₹12.51 ₹12.15 ₹7.13 ₹7.09 ₹10.48 ₹7.30
Industry Peers & Returns1W1M1Y
MANKIND PHARMA 2.1% -4.1% 24.2%
SUN PHARMACEUTICAL INDUSTRIES -0% 5% 47.2%
CIPLA 0.3% -1.8% 47.2%
DR REDDYS LABORATORIES 3.2% 11.5% 30.2%
ZYDUS LIFESCIENCES 1.9% 9% 100.9%
DIVIS LABORATORIES 0.5% -0.4% 24.7%
TORRENT PHARMACEUTICALS 0.5% 2.7% 52%
LUPIN 1.1% 14.1% 96.9%
AUROBINDO PHARMA 3.1% 9.5% 80.3%

MANKIND PHARMA Quarterly Revenues

Revenues
Q-o-Q

-6.36 %

Y-o-Y

18.92 %

Quarters Revenues % Change
Mar2024 ₹2,441 Cr
-6.36
Dec2023 ₹2,607 Cr
-3.73
Sep2023 ₹2,708 Cr
5.02
Jun2023 ₹2,579 Cr
25.62
Mar2023 ₹2,053 Cr
-1.83
Dec2022 ₹2,091 Cr
-13.81
Sep2022 ₹2,426 Cr
11.28
Jun2022 ₹2,180 Cr -

MANKIND PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-2.54 %

Y-o-Y

41.86 %

Quarters Operating Profit % Change
Mar2024 ₹591 Cr
-2.54
Dec2023 ₹607 Cr
-11.15
Sep2023 ₹683 Cr
4.25
Jun2023 ₹655 Cr
57.15
Mar2023 ₹417 Cr
-4.66
Dec2022 ₹437 Cr
-26.01
Sep2022 ₹591 Cr
29.48
Jun2022 ₹456 Cr -
Operating Margins
Q-o-Q

4.08 %

Y-o-Y

19.26 %

Quarters Operating Margin% % Change
Mar2024 24.21%
4.08
Dec2023 23.26%
-7.74
Sep2023 25.21%
-0.71
Jun2023 25.39%
25.07
Mar2023 20.3%
-2.87
Dec2022 20.9%
-14.17
Sep2022 24.35%
16.34
Jun2022 20.93% -

MANKIND PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

4.17 %

Y-o-Y

62.99 %

Quarters Profit After Tax % Change
Mar2024 ₹474 Cr
4.17
Dec2023 ₹455 Cr
-10.34
Sep2023 ₹508 Cr
3.73
Jun2023 ₹489 Cr
68.24
Mar2023 ₹291 Cr
-0.83
Dec2022 ₹293 Cr
-29.95
Sep2022 ₹419 Cr
42.37
Jun2022 ₹294 Cr -
PAT Margins
Q-o-Q

11.23 %

Y-o-Y

37.05 %

Quarters PAT Margin(%) % Change
Mar2024 19.42 %
11.23
Dec2023 17.46 %
-6.88
Sep2023 18.75 %
-1.21
Jun2023 18.98 %
33.94
Mar2023 14.17 %
1.00
Dec2022 14.03 %
-18.71
Sep2022 17.26 %
27.95
Jun2022 13.49 % -

MANKIND PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

3.80 %

Y-o-Y

64.94 %

Quarters EPS % Change
Mar2024 ₹11.76
3.80
Dec2023 ₹11.33
-9.43
Sep2023 ₹12.51
2.96
Jun2023 ₹12.15
70.41
Mar2023 ₹7.13
0.56
Dec2022 ₹7.09
-32.35
Sep2022 ₹10.48
43.56
Jun2022 ₹7.3 -

You may also like the below Video Courses